The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Nuclear factor-κB in cancer development and progression
Abstract
Nuclear factor-kappaB (NF-kappaB) transcription factors and the signalling pathways that activate them are central coordinators of innate and adaptive immune responses. More recently, it has become clear that NF-kappaB signalling also has a critical role in cancer development and progression. NF-kappaB provides a mechanistic link between inflammation and cancer, and is a major factor controlling the ability of both pre-neoplastic and malignant cells to resist apoptosis-based tumour-surveillance mechanisms. NF-kappaB might also regulate tumour angiogenesis and invasiveness, and the signalling pathways that mediate its activation provide attractive targets for new chemopreventive and chemotherapeutic approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When NF-κB is activated, transcription of proinflammatory immune response genes such as Tnfα and Il1 occurs, which leads to translation and production of proinflammatory cytokines that serve to coordinate the inflammatory response (Karin, 2006).”
From Sleep health: Reciprocal regulation of sleep and innate immunity (2017) · cites this paper as Karin, 2006
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Self-citationDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Self-citationNF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,010
Abid, R., Ghazanfar, S., Farid, A., Sulaman, S. M., Idrees, M., Amen, R. A., Muzammal, M., Shahzad, M. K., Mohamed, M. O., Khaled, A. A., et al. (2022) · Molecules · doi:10.3390/molecules27134304 · Cited by 86
Qiu, P., Wang, L., Zuo, L., Gao, S., Jiang, X., Han, Y., Lin, J., Peng, M., Wu, N., Tang, Y., et al. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00682-3 · Cited by 85
The Role of Inflammation in Cervical Cancer
Sankaran, D., Marzook, K. H., & Pillai, M. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_15 · Cited by 79
Logunov, D. Y., Scheblyakov, D. V., Zubkova, O. V., Шмаров, М. М., Rakovskaya, I. V., Gurova, K. V., Tararova, N. D., Burdelya, L. G., Naroditsky, B. S., Ginzburg, A., et al. (2008) · Oncogene · doi:10.1038/onc.2008.103 · Cited by 79
Constitutive noncanonical NFκB signaling in pancreatic cancer cells
Wharry, C. E., Haines, K. M., Carroll, R. G., & May, M. J. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.16.8961 · Cited by 79
Zhu, W., Ou, Y., Li, Y., Xiao, R. D., Shu, M., Zhou, Y., Xie, J. X., He, S., Qiu, P., & Yan, G. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.052605 · Cited by 79
Jackson, A. F., Williams, A., Recio, L., Waters, M. D., Lambert, I. B., & Yauk, C. L. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.019 · Cited by 78
p62 as a therapeutic target for tumor
Tao, M., Liu, T., You, Q., & Jiang, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112231 · Cited by 77
Sangaran, P. G., Ibrahim, Z. A., Chik, Z., Mohamed, Z., & Ahmadiani, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02227-3 · Cited by 78
Shao, N., Lu, Z., Zhang, Y., Wang, M., Li, W., Hu, Z., Wang, S., & Lin, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.009 · Cited by 78
Song, H. Y., Lee, J. A., Ju, S. M., Yoo, K., Won, M. H., Kwon, H., Eum, W. S., Jang, S. H., Choi, S. Y., & Park, J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.015 · Cited by 78
Breast Cancer Chemoprevention: Old and New Approaches
Cazzaniga, M., & Bonanni, B. (2012) · BioMed Research International · doi:10.1155/2012/985620 · Cited by 82
Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis.
Sesti, F., Tsitsilonis, O., Kotsinas, A., & Trougakos, I. P. (2012) · PubMed · Cited by 78
Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis
Haxho, F., Neufeld, R. J., & Szewczuk, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.8396 · Cited by 78
Agnoli, C., Grioni, S., Pala, V. M., Allione, A., Matullo, G., Gaetano, C. D., Tagliabue, G., Sieri, S., & Krogh, V. (2017) · Scientific Reports · doi:10.1038/s41598-017-12703-x · Cited by 78
Feng, Y., Duan, T., Du, Y., Jin, S., Wang, M., Cui, J., & Wang, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-12573-3 · Cited by 78
Buhrmann, C., Shayan, P., Banik, K., Kunnumakkara, A. B., Kubatka, P., Koklesová, L., & Shakibaei, M. (2020) · Biomedicines · doi:10.3390/biomedicines8080236 · Cited by 77
Liu, H., Du, J., Chao, S., Li, S., Cai, H., Zhang, H., Chen, G., Liu, P., & Bu, P. (2022) · Advanced Science · doi:10.1002/advs.202105222 · Cited by 73
Chronic Inflammation and Hepatocellular Carcinoma
Alison, M. R., Nicholson, L. J., & Lin, W. (2011) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-03503-6_8 · Cited by 77
The value of proteasome inhibition in cancer
Cvek, B., & Dvořák, Z. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.003 · Cited by 78
Role of TLR2‐dependent inflammation in metastatic progression
Kim, S.-H., & Karin, M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05882.x · Cited by 78
Self-citationWang, Z., Liu, B., Wang, P., Dong, X., Fernandez-Hernando, C. F., Zhong, L., Hla, T., Li, Z., Claffey, K. P., Smith, J. D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33139 · Cited by 79
Schmieder, A., Multhoff, G., & Radons, J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.06.286 · Cited by 77
Bcl3 Selectively Promotes Metastasis of ERBB2-Driven Mammary Tumors
Wakefield, A., Soukupová, J., Montagne, A., Ranger, J. J., French, R., Muller, W. J., & Clarkson, R. W. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1321 · Cited by 77
miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males
Jiang, R., Deng, L., Zhao, L., Li, X., Zhang, F., Xia, Y., Gao, Y., Wang, X., & Sun, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1734 · Cited by 79
Mollen, K. P., Levy, R. M., Prince, J. M., Hoffman, R. A., Scott, M. J., Kaczorowski, D. J., Vallabhaneni, R., Yoram Vodovotz, B., & Billiar, T. R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407201 · Cited by 77
Mechanism of the Anticancer Effect of Lycopene (Tetraterpenoids)
Ono, M., Takeshima, M., & Nakano, S. (2015) · The Enzymes · doi:10.1016/bs.enz.2015.06.002 · Cited by 77
Wang, D., Gao, Q., Zhao, G., Kan, Z., Wang, X., Wang, H., Huang, J., Wang, T., Qian, F., Ho, C., et al. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b02293 · Cited by 80
MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma
Zehavi, L., Schayek, H., Jacob‐Hirsch, J., Sidi, Y., Leibowitz‐Amit, R., & Avni, D. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0338-9 · Cited by 77
Precancerous lesions in inflammatory bowel disease
Harpaz, N., Ward, S. C., Mescoli, C., Itzkowitz, S. H., & Polydorides, A. D. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.014 · Cited by 76
Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma
Purohit, V., Rapaka, R. S., Kwon, O. S., & Song, B. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.10.009 · Cited by 76
Beneficial and Detrimental Roles of NLRs in Carcinogenesis
Janowski, A. M., Kolb, R. H., Zhang, W., & Sutterwala, F. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00370 · Cited by 79
Fan, Y., Xue, W., Schachner, M., & Zhao, W. (2018) · Cancers · doi:10.3390/cancers11010022 · Cited by 76
Ashrafizadeh, M., Rafiei, H., Mohammadinejad, R., Farkhondeh, T., & Samarghandian, S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01773-7 · Cited by 79
Liu, S., He, L., Wu, J., Wu, X., Xie, L., Dai, W., Chen, L., Xie, F., & Liu, Z. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04013-3 · Cited by 76
The role of autophagy in cancer: from molecular mechanism to therapeutic window
Jalali, P., Shahmoradi, A., Samii, A., Mazloomnejad, R., Hatamnejad, M. R., Saeed, A., Namdar, A., & Salehi, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1528230 · Cited by 89
Colon carcinogenesis: Learning from NF-κB and AP-1
Vaiopoulos, G., Papachroni, K. K., & Papavassiliou, A. G. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.03.018 · Cited by 76
He, D., Xu, Q., Yan, M., Zhang, P., Zhou, X., Zhang, Z., Duan, W., Zhong, L., Ye, D., & Chen, W. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-343 · Cited by 78
Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors
Mejías‐Luque, R., Lindén, S. K., Garrido, M., Tye, H., Najdovska, M., Jenkins, B. J., Iglesias, M., Ernst, M., & de Bolós, C. (2010) · Oncogene · doi:10.1038/onc.2009.467 · Cited by 76
Inflammation and lung carcinogenesis: applying findings in prevention and treatment
Peebles, K. A., Lee, J. M., Mao, J. T., Hazra, S., Reckamp, K. L., Krysan, K., Dohadwala, M., Heinrich, E. L., Walser, T. C., Cui, X., et al. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.10.1405 · Cited by 77
Marine Diterpenoids as Potential Anti‐Inflammatory Agents
González, Y., Torres‐Mendoza, D., Jones, G. E., & Fernández, P. L. (2015) · Mediators of Inflammation · doi:10.1155/2015/263543 · Cited by 76
Oh, J., Sinha, I., Tan, K. Y., ROSNER, B. A., Dreyfuss, J. M., Gjata, O., Tran, P. H., Shoelson, S. E., & Wagers, A. J. (2016) · Aging · doi:10.18632/aging.101098 · Cited by 78
Mulrooney, T. J., Marsh, J., Urits, I., Seyfried, T. N., & Mukherjee, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018085 · Cited by 75
Shakhov, A. N., Singh, V. K., Bone, F., Cheney, A., Kononov, Y., Krasnov, P. A., Bratanova-Tochkova, T. K., Shakhova, V. V., Young, J., Weil, M. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033044 · Cited by 75
The potential role of vitamin C in empowering cancer immunotherapy
Bedhiafi, T., Inchakalody, V. P., Fernandes, Q., Mestiri, S., Billa, N., Shahab Uddin, M. S., Merhi, M., & Dermime, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112553 · Cited by 77
Pancreatic cancer risk in hereditary pancreatitis
Weiß, F. U. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00070 · Cited by 75
Clinical significance of CYLD downregulation in breast cancer
Hayashi, M., Jono, H., Shinriki, S., Nakamura, T., Guo, J., Sueta, A., Tomiguchi, M., Fujiwara, S., Yamamoto‐Ibusuki, M., Murakami, K.-I., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2824-3 · Cited by 75
Zhou, A. Y., Shen, R. R., Kim, E., Lock, Y. J., Xu, M., Chen, Z. J., & Hahn, W. C. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.031 · Cited by 79
Atkinson, G. P., Nozell, S. E., Harrison, D. K., Stonecypher, M. S., Chen, D., & Benveniste, E. N. (2009) · Oncogene · doi:10.1038/onc.2009.232 · Cited by 75
IKKβ links vascular inflammation to obesity and atherosclerosis
Sui, Y., Park, S., Xu, J., Monette, S., Helsley, R. N., Han, S., & Zhou, C. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131281 · Cited by 75
Oh, K., Ko, E., Kim, H. S., Park, A. K., Moon, H., Noh, D., & Lee, D. (2011) · Breast Cancer Research · doi:10.1186/bcr3034 · Cited by 75
Current Knowledge on Pancreatic Cancer
Iovanna, J., Mallmann, M. C., Gonçalvès, A., Turrini, O., & Dagorn, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00006 · Cited by 74
Zhou, J., Gu, S.-S., Mei, W. H., Zhou, J., Wang, Z. Z., & Xiao, W. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0728-y · Cited by 75
Ma, Z., Chalkley, R. J., & Vosseller, K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.766568 · Cited by 79
Inflammation in Prostatic Hyperplasia and Carcinoma—Basic Scientific Approach
Krušlin, B., Tomas, D., Dzombeta, T. R., Periša, M. M., & Ulamec, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00077 · Cited by 75
NF-κB pathway in colitis-associated cancers.
Viennois, É., Chen, F., & Merlin, D. (2013) · PubMed · doi:10.3978/j.issn.2224-4778.2012.11.01 · Cited by 78
Ding, J., Zhao, J., Huan, L., Liu, Y., Qiao, Y., Wang, Z., Chen, Z., Huang, S., Zhao, Y., & He, X. (2020) · Hepatology · doi:10.1002/hep.31195 · Cited by 74
Salaün, C., Leroy, C., Rousseau, A., Boitez, V., Beck, L., & Friedlander, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.130989 · Cited by 78
Nishio, H., Yaguchi, T., Sugiyama, J., Sumimoto, H., Umezawa, K., Iwata, T., Susumu, N., Fujii, T., Kawamura, N., Kobayashi, A., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.251 · Cited by 74
Chittezhath, M., Deep, G., Singh, R. P., Agarwal, C., & Agarwal, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0256 · Cited by 74
Dynamic activation of the key pathways: linking colitis to colorectal cancer in a mouse model
Tang, A., Li, N., Li, X., Yang, H., Wang, W., Zhang, L., Li, G., Xiong, W., Ma, J., & Shen, S. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs183 · Cited by 73
Nuclear Factor-κB, an Unappreciated Tumor Suppressor
Chen, F., & Castranova, V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1576 · Cited by 74
A set of NF-κB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer
Jeon, Y.-J., Middleton, J. D., Kim, T., Laganà, A., Piovan, C., Secchiero, P., Nuovo, G. J., Cui, R., Joshi, P., Romano, G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504630112 · Cited by 73
A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death
Catrysse, L., Ghahremani, M., Vereecke, L., Youssef, S., Guire, C. M., Sze, M., Weber, A., Heikenwalder, M., de Bruin, A., Beyaert, R., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.154 · Cited by 71
Regulation of microglia polarization after cerebral ischemia
Wang, H., Li, J., Zhang, H., Wang, M., Xiao, L., Wang, Y., & Cheng, Q. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1182621 · Cited by 81
Sugimoto, N., Miwa, S., Hitomi, Y., Nakamura, H., Tsuchiya, H., & Yachie, A. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2013.877497 · Cited by 73
Radioprotection: smart games with death
Gudkov, A. V., & Komarova, E. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43794 · Cited by 75
Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis
Grover, P. K., Hardingham, J. E., & Cummins, A. G. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9262-z · Cited by 74
Regional anaesthesia and cancer metastases: the implication of local anaesthetics
Votta-Velis, E. G., Piegeler, T., Minshall, R. D., Aguirre, J. A., Beck‐Schimmer, B., Schwartz, D. E., & Borgeat, A. (2013) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12210 · Cited by 73
Plasma brain natriuretic peptide levels are elevated in patients with cancer
Bando, S., Soeki, T., Matsuura, T., Tobiume, T., Ise, T., Kusunose, K., Yamaguchi, K., Yagi, S., Fukuda, D., Iwase, T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178607 · Cited by 73
Shankar, E., Zhang, A., Franco, D., & Gupta, S. (2017) · Molecules · doi:10.3390/molecules22020264 · Cited by 73
Wu, Y., Huang, Y., Chang, T., & Chou, C. (2017) · International Journal of Cancer · doi:10.1002/ijc.30932 · Cited by 72
Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
Zhang, S., Cai, S., & Ma, Y. (2018) · Journal of Cancer · doi:10.7150/jca.24048 · Cited by 77
Buhrmann, C., Popper, B., Kunnumakkara, A. B., Aggarwal, B. B., & Shakibaei, M. (2019) · Nutrients · doi:10.3390/nu11122904 · Cited by 72
Zhao, Y., Yao, J., Wu, X., Zhao, L., Zhou, Y., Zhang, Y., You, Q., Guo, Q., & Lu, N. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22182 · Cited by 73
Jeon, Y., Kim, D.-H., Jung, H., Chung, S. J., Chi, S., Cho, S., Lee, S. C., Park, B. C., Park, S. G., & Bae, K. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0331-9 · Cited by 72
Saito, A., Suzuki, H. I., Horie, M., Ohshima, M., Morishita, Y., Abiko, Y., & Nagase, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056587 · Cited by 72
Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes
Andersen, V. C., Christensen, J., Overvad, K., Tjønneland, A. M., & Vogel, U. B. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-484 · Cited by 72
Johnson, G. E., Ivanov, V. N., & Hei, T. K. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0212-y · Cited by 72
To fight or die — inhibitor of apoptosis proteins at the crossroad of innate immunity and death
Lopez, J. S., & Meier, P. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.025 · Cited by 71
Necroptosis in cancer: An angel or a demon?
Wang, T., Jin, Y., Yang, W., Zhang, L., Jin, X., Liu, X., He, Y., & Li, X. (2017) · Tumor Biology · doi:10.1177/1010428317711539 · Cited by 72
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Xue, Y., Ruan, Y., Wang, Y., Xiao, P., & Xu, J. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00184-0 · Cited by 87
Takata, A., Otsuka, M., Kojima, K., Yoshikawa, T., Kishikawa, T., Yoshida, H., & Koike, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.048 · Cited by 72
OGDHL Is a Modifier of AKT-Dependent Signaling and NF-κB Function
Sen, T., Sen, N., Noordhuis, M. G., Ravi, R. K., Wu, T. ‐., Ha, P. K., Sidransky, D., & Hoque, M. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048770 · Cited by 71
Li, T. W. H., Yang, H., Peng, H., Xia, M., Mato, J. M., & Lu, S. C.-L. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr295 · Cited by 72
Decoys and Regulatory “Receptors” of the IL-1/Toll-Like Receptor Superfamily
Garlanda, C., Riva, F., Bonavita, E., Gentile, S., & Mantovani, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00180 · Cited by 72
Real-Time Monitoring of Nuclear Factor κB Activity in Cultured Cells and in Animal Models
Badr, C. E., Niers, J. M., Tjon‐Kon‐Fat, L., Noske, D. P., Würdinger, T., & Tannous, B. A. (2009) · Molecular Imaging · doi:10.2310/7290.2009.00026 · Cited by 72
Significance of microRNA 21 in gastric cancer
Sekar, D., Ramalingam, K., Thirugnanasambantham, K., Rajasekaran, B., Islam, V. I. H., & Sekar, P. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.02.010 · Cited by 75
Bommarito, A., Richiusa, P., Carissimi, E., Pizzolanti, G., Rodolico, V., Zito, G., Criscimanna, A., Di Blasi, F., Pitrone, M., Zerilli, M., et al. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0076 · Cited by 70
Wang, L., Yu, P., Li, B., Guo, Y., Liang, Z., Zheng, L., Yang, J., Xu, H. M., Liu, S., Zheng, L., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12376 · Cited by 69
Seyfried, T. N., Marsh, J., Shelton, L. M., Huysentruyt, L. C., & Mukherjee, P. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.06.017 · Cited by 71
Regulation of NF-κB activity by competition between RelA acetylation and ubiquitination
Li, H., Wittwer, T., Weber, A., Schneider, H., Moreno, R., Maine, G. N., Kracht, M., Schmitz, M. L., & Burstein, E. (2011) · Oncogene · doi:10.1038/onc.2011.253 · Cited by 70
Chang, M. S., Kim, D. H., Roh, J., Middeldorp, J. M., Kim, Y. S., Kim, S., Han, S., Kim, C. W., Lee, B. L., Kim, W. H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00955-13 · Cited by 70
Zheng, J., Lee, H. L., Ham, Y. W., Song, H. S., Song, M. J., & Hong, J. T. (2015) · Oncotarget · doi:10.18632/oncotarget.6295 · Cited by 70
Targeting AKT protein kinase in gastric cancer.
Almhanna, K., Strosberg, J., & Malafa, M. P. (2011) · PubMed · Cited by 70
Pan, Y., Lin, S., Xing, R., Zhu, M., Lin, B., Cui, J., Li, W., Gao, J., Shen, L., Zhao, Y., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6128 · Cited by 70
Popolo, A., Pinto, A., Daglia, M., Nabavi, S. F., Farooqı, A. A., & Rastrelli, L. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.002 · Cited by 70
miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer
Wa, Q., Huang, S., Pan, J., Tang, Y., He, S., Fu, X., Peng, X., Chen, X., Yang, C., Ren, D., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.008 · Cited by 70
Dipyridamole prevents triple-negative breast-cancer progression
Spano, D., Marshall, J. –. A., Marino, N., Martino, D. D., Romano, A., Scoppettuolo, M. N., Bello, A. M., Dato, V. D., Navas, L., Vita, G. D., et al. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9506-0 · Cited by 70
Papa, S., Monti, S. M., Vitale, R. M., Bubici, C., Jayawardena, S., Alvarez, K., Smaele, E. D., Dathan, N. A., Pedone, C., Ruvo, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703112200 · Cited by 70
Metadata
- Authors
- Karin, M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- ORCID
- Karin, Michael
- Venue
- Nature
- Published
- 2006-05
- Volume
- 441
- Issue
- 7092
- Pages
- 431-436
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2315613727
- Cited by
- 3,519
- References
- 71
- Citations by year
- 2026: 60 · 2025: 97 · 2024: 111 · 2023: 118 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 133 · 2018: 168 · 2017: 149 · 2016: 192 · 2015: 235 · 2014: 203 · 2013: 231 · 2012: 250
- FWCI
- 15.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- NF-κB, carcinogenesis, tumor progression, inflammation and cancer, apoptosis resistance, tumor surveillance, tumor angiogenesis, tumour invasiveness, chemoprevention, chemotherapeutic target, NF-κB signaling
- MeSH terms
- Animals, Humans, Inflammation, Liver Neoplasms, Neoplasms, Skin Neoplasms, NF-kappa B, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review